Vascular disease disproportionately impacts Black Americans. Here are three warning signs you should never ignore.
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback